↓ Skip to main content

Dove Medical Press

Ropivacaine with Dexmedetomidine or Dexamethasone in a Thoracic Paravertebral Nerve Block Combined with an Erector Spinae Plane Block for Thoracoscopic Lobectomy Analgesia: A Randomized Controlled…

Overview of attention for article published in Drug Design, Development and Therapy, May 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
19 Mendeley
Title
Ropivacaine with Dexmedetomidine or Dexamethasone in a Thoracic Paravertebral Nerve Block Combined with an Erector Spinae Plane Block for Thoracoscopic Lobectomy Analgesia: A Randomized Controlled Trial
Published in
Drug Design, Development and Therapy, May 2022
DOI 10.2147/dddt.s366428
Pubmed ID
Authors

Jing Yang, Min Zhao, Xiao-Rui Zhang, Xiao-Rui Wang, Zhi-Hao Wang, Xiao-Yue Feng, Ya-Juan Lei, Jian-Wen Zhang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 16%
Researcher 1 5%
Unknown 15 79%
Readers by discipline Count As %
Medicine and Dentistry 4 21%
Immunology and Microbiology 1 5%
Unknown 14 74%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2022.
All research outputs
#17,865,428
of 26,169,168 outputs
Outputs from Drug Design, Development and Therapy
#1,143
of 2,295 outputs
Outputs of similar age
#271,736
of 450,745 outputs
Outputs of similar age from Drug Design, Development and Therapy
#15
of 36 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,295 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,745 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.